Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seiichiro Ozono

Showing results (1-10 of 194) with videos related to

Pageof 20
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 8, 2013
[Paradigm shift of chemotherapy for kidney cancer]Seiichiro Ozono
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 25, 2014
[Nivolumab (Anti-PD-1 antibody; ONO-4538/BMS-936558) in renal cancer]Seiichiro Ozono
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 19, 2014
[Role of urologists in the era of new treatment modalities for CRPC in Japan]Seiichiro Ozono
International Journal of Urology : Official Journal of the Japanese Urological Association|July 24, 2010
Transurethral resection of the bladder tumour (TURBT) for non-muscle invasive bladder cancer: basic skillsHiroshi Furuse, Seiichiro Ozono
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 12, 2013
[Novel molecular-targeted drug for renal cancer(AXIS trial)]Seiichiro Ozono, Tatsuya Takayama
Nihon Rinsho. Japanese Journal of Clinical Medicine|December 19, 2014
[Chemotherapy for CRPC]Seiichiro Ozono, Hiroshi Furuse
Nihon Rinsho. Japanese Journal of Clinical Medicine|June 28, 2016
[Prognostic factors in patients with castration-resistant prostate cancer]Hiroshi Furuse, Seiichiro Ozono
Nihon Rinsho. Japanese Journal of Clinical Medicine|June 28, 2016
[Progress of the treatment for CRPC]Seiichiro Ozono, Hiroshi Furuse
Nihon Rinsho. Japanese Journal of Clinical Medicine|December 15, 2018
Drug therapy for renal cell carcinoma in the elderlyHideaki Miyake, Seiichiro Ozono
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 25, 2018
[II .Problems of Treatment for Non-Muscle Invasive Bladder Cancer]Seiichiro Ozono, Hiroshi Furuse
Pageof 20

Showing results (1-10 of 194) with videos related to

Sort By:
Pageof 20
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 8, 2013
[Paradigm shift of chemotherapy for kidney cancer]Seiichiro Ozono
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 25, 2014
[Nivolumab (Anti-PD-1 antibody; ONO-4538/BMS-936558) in renal cancer]Seiichiro Ozono
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 19, 2014
[Role of urologists in the era of new treatment modalities for CRPC in Japan]Seiichiro Ozono
International Journal of Urology : Official Journal of the Japanese Urological Association|July 24, 2010
Transurethral resection of the bladder tumour (TURBT) for non-muscle invasive bladder cancer: basic skillsHiroshi Furuse, Seiichiro Ozono
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 12, 2013
[Novel molecular-targeted drug for renal cancer(AXIS trial)]Seiichiro Ozono, Tatsuya Takayama
Nihon Rinsho. Japanese Journal of Clinical Medicine|December 19, 2014
[Chemotherapy for CRPC]Seiichiro Ozono, Hiroshi Furuse
Nihon Rinsho. Japanese Journal of Clinical Medicine|June 28, 2016
[Prognostic factors in patients with castration-resistant prostate cancer]Hiroshi Furuse, Seiichiro Ozono
Nihon Rinsho. Japanese Journal of Clinical Medicine|June 28, 2016
[Progress of the treatment for CRPC]Seiichiro Ozono, Hiroshi Furuse
Nihon Rinsho. Japanese Journal of Clinical Medicine|December 15, 2018
Drug therapy for renal cell carcinoma in the elderlyHideaki Miyake, Seiichiro Ozono
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 25, 2018
[II .Problems of Treatment for Non-Muscle Invasive Bladder Cancer]Seiichiro Ozono, Hiroshi Furuse
Pageof 20